Altamira Therapeutics : Notice of Extension to Comply with Continued Listing Rule
Notice of Extension to Comply with Continued Listing Rule As previously announced, on May 25, 2023, the Nasdaq Listing Qualifications staff notified Altamira Therapeutics Ltd. ...